Borealis AG - Strategic SWOT Analysis Review
Borealis AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights
Borealis AG (Borealis) a subsidiary of Mubadala Investment Co, is a provider of solutions in the fields of polyolefins, base chemicals and fertilizers. It manufactures and commercializes polyethylene and polypropylene. The company's product portfolio consists of melamine, phenol, acetone, and ethylene, propylene and polyolefin compounds. Borealis also provides plastics solutions to the infrastructure, automotive, and advanced packaging industries. The company develops these products using its proprietary Borstar and Borlink technologies. It operates through a network of innovation centers, manufacturing facilities, customer service centers and representative offices, subsidiaries, and affiliates. The company has operations in EU countries, the US, Middle East and Asia. Borealis is headquartered in Vienna, Austria.
Borealis AG Key Recent Developments
Mar 17,2021: Borealis appoints Katja Tautscher as senior vice president legal and compliance
Mar 08,2021: Leo Alders appointed acting CEO of Borealis fertilizers, melamine and technical nitrogen business
Feb 11,2021: Gasum joins forces with Stena Renewable in Sweden to deliver wind power to Borealis
Feb 05,2021: Thomas Gangl appointed new Borealis CEO as of 1 April 2021
Feb 04,2021: Borealis delivers solid financial result for 2020 in volatile market environment
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.